Renovamed
An open-core prescription-renewal preparation and oversight workspace for public-health and safety-net providers that assembles patient evidence, applies versioned program criteria, routes licensed decisions, and records prescribing-system acknowledgment and correction.
Chronic-medication renewal can consume clinical time even when a patient appears stable, but the required facts, labs, encounters, adherence evidence, contraindications, prescriber relationship, state rules, and sandbox conditions vary. Renovamed prepares a renewal candidate and evidence packet for the licensed professional and approved program. It never turns a software score, open skill, or state-policy summary into prescribing authority. The confirmed Utah program begins with physician oversight and reserves autonomy for a later phase; no multi-state autonomous rollout may be inferred from that pilot.
The clinical operations, medical, pharmacy, digital-health, or public-health owner at a safety-net provider or approved program, with licensed prescribers and pharmacists retaining patient-specific authority.
The January 2026 Utah agreement and cited funding round provide a recent regulatory and market trigger.
Evidence assembly, rules, workflow, and interfaces scale in software, but licensed review, program approval, and patient safety constrain pure replication.
Two cross-references, four inbound connections, and three direct connections support adjacency without strong independent convergence.
An official Utah sandbox agreement, a cited 192-medicine scope, a $40 million funding signal, and an open-core public-health angle create a sharp current regulatory and delivery wedge.
The buyer quartet is incomplete, the confirmed pathway is one phased sandbox with physician oversight, multi-state claims are exploratory, proposed prices are unobserved, and software leverage is constrained by licensed clinical operations.
Discussion
No comments yet — be the first to weigh in.